Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029129
Filing Date
2025-02-27
Accepted
2025-02-27 16:30:37
Documents
122
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sln-20241231.htm   iXBRL 10-K 3684236
2 EX-4.3 sln-ex4_3.htm EX-4.3 249486
3 EX-19.1 sln-ex19_1.htm EX-19.1 200476
4 EX-23.1 sln-ex23_1.htm EX-23.1 3487
5 EX-31.1 sln-ex31_1.htm EX-31.1 20400
6 EX-31.2 sln-ex31_2.htm EX-31.2 20233
7 EX-32.1 sln-ex32_1.htm EX-32.1 16659
8 GRAPHIC img172674775_0.jpg GRAPHIC 179575
9 GRAPHIC img172674775_1.jpg GRAPHIC 1127282
10 GRAPHIC img172674775_2.jpg GRAPHIC 162840
  Complete submission text file 0000950170-25-029129.txt   18375706

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20241231.xsd EX-101.SCH 1317116
125 EXTRACTED XBRL INSTANCE DOCUMENT sln-20241231_htm.xml XML 3223138
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 10-K | Act: 34 | File No.: 001-39487 | Film No.: 25679576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)